245 / 1631
Event-free Survival (%)
100
80
60
40
20
0
0
2
4
6
8
10
Time since Randomization (year)
3-MOPP-ABV + IF (n=270)
STNI (n=272)
P <0.001
Ferme et al; NEJM 2007
EORTC H8F Clinical Trial
FFTF for pts with early favorable
HL
|
|
245 / 1631
Event-free Survival (%)
100
80
60
40
20
0
0
2
4
6
8
10
Time since Randomization (year)
3-MOPP-ABV + IF (n=270)
STNI (n=272)
P <0.001
Ferme et al; NEJM 2007
EORTC H8F Clinical Trial
FFTF for pts with early favorable
HL